Ironwood Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $497K | Buy |
17,703
+1,009
| +6% | +$26.9K | 0.07% | 178 |
|
|
2025
Q4 | $416K | Sell |
16,694
-156
| -0.9% | -$3.93K | 0.06% | 186 |
|
|
2025
Q3 | $429K | Buy |
16,850
+313
| +2% | +$7.72K | 0.06% | 186 |
|
|
2025
Q2 | $401K | Sell |
16,537
-539
| -3% | -$12.6K | 0.06% | 182 |
|
|
2025
Q1 | $433K | Buy |
17,076
+769
| +5% | +$20.1K | 0.07% | 169 |
|
|
2024
Q4 | $433K | Sell |
16,307
-3,750
| -19% | -$102K | 0.07% | 170 |
|
|
2024
Q3 | $580K | Sell |
20,057
-3,875
| -16% | -$113K | 0.1% | 158 |
|
|
2024
Q2 | $670K | Buy |
23,932
+1,205
| +5% | +$33.2K | 0.12% | 146 |
|
|
2024
Q1 | $631K | Sell |
22,727
-8,983
| -28% | -$249K | 0.11% | 152 |
|
|
2023
Q4 | $913K | Sell |
31,710
-8,929
| -22% | -$270K | 0.17% | 119 |
|
|
2023
Q3 | $1.35M | Buy |
40,639
+1,913
| +5% | +$67.6K | 0.28% | 89 |
|
|
2023
Q2 | $1.42M | Sell |
38,726
-4,476
| -10% | -$174K | 0.32% | 74 |
|
|
2023
Q1 | $1.76M | Sell |
43,202
-1,245
| -3% | -$53.8K | 0.42% | 69 |
|
|
2022
Q4 | $2.28M | Sell |
44,447
-5,918
| -12% | -$284K | 0.55% | 57 |
|
|
2022
Q3 | $2.2M | Sell |
50,365
-12,110
| -19% | -$588K | 0.63% | 50 |
|
|
2022
Q2 | $3.27M | Sell |
62,475
-2,236
| -3% | -$114K | 0.92% | 33 |
|
|
2022
Q1 | $3.35M | Sell |
64,711
-63,399
| -49% | -$3.29M | 0.82% | 40 |
|
|
2021
Q4 | $7.56M | Buy |
128,110
+1,068
| +0.8% | +$52.9K | 1.73% | 13 |
|
|
2021
Q3 | $5.46M | Buy |
127,042
+3,718
| +3% | +$165K | 1.4% | 24 |
|
|
2021
Q2 | $4.83M | Buy |
123,324
+2,350
| +2% | +$91.4K | 1.28% | 26 |
|
|
2021
Q1 | $4.38M | Sell |
120,974
-23,241
| -16% | -$825K | 1.26% | 26 |
|
|
2020
Q4 | $5.31M | Buy |
144,215
+5,659
| +4% | +$208K | 1.21% | 27 |
|
|
2020
Q3 | $4.82M | Buy |
138,556
+4,715
| +4% | +$165K | 1.31% | 21 |
|
|
2020
Q2 | $4.15M | Buy |
133,841
+12,956
| +11% | +$440K | 1.27% | 25 |
|
|
2020
Q1 | $3.74M | Buy |
120,885
+17,462
| +17% | +$595K | 1.47% | 18 |
|
|
2019
Q4 | $3.84M | Buy |
103,423
+1,659
| +2% | +$59.1K | 1.32% | 25 |
|
|
2019
Q3 | $3.47M | Buy |
101,764
+2,919
| +3% | +$106K | 1.28% | 25 |
|
|
2019
Q2 | $4.06M | Buy |
98,845
+490
| +0.5% | +$19.5K | 1.55% | 19 |
|
|
2019
Q1 | $3.96M | Sell |
98,355
-3,887
| -4% | -$156K | 1.56% | 20 |
|
|
2018
Q4 | $4.23M | Sell |
102,242
-4,577
| -4% | -$190K | 1.86% | 11 |
|
|
2018
Q3 | $4.47M | Buy |
106,819
+1,074
| +1% | +$41.3K | 1.73% | 14 |
|
|
2018
Q2 | $3.64M | Buy |
105,745
+4,374
| +4% | +$149K | 1.59% | 19 |
|
|
2018
Q1 | $3.41M | Buy |
101,371
+44,985
| +80% | +$1.55M | 1.52% | 21 |
|
|
2017
Q4 | $1.94M | Buy |
56,386
+1,345
| +2% | +$45.9K | 0.71% | 39 |
|
|
2017
Q3 | $1.86M | Buy |
55,041
+4,072
| +8% | +$131K | 0.75% | 36 |
|
|
2017
Q2 | $1.65M | Hold |
50,969
| – | – | 0.62% | 45 |
|
|
2017
Q1 | $1.65M | Buy |
50,969
+6,779
| +15% | +$214K | 0.69% | 46 |
|
|
2016
Q4 | $1.36M | Sell |
44,190
-63,834
| -59% | -$1.95M | 0.61% | 48 |
|
|
2016
Q3 | $3.47M | Buy |
108,024
+16,282
| +18% | +$544K | 1.62% | 16 |
|
|
2016
Q2 | $3.06M | Sell |
91,742
-9,815
| -10% | -$313K | 1.79% | 14 |
|
|
2016
Q1 | $2.85M | Buy |
101,557
+4,190
| +4% | +$120K | 1.49% | 19 |
|
|
2015
Q4 | $2.98M | Buy |
97,367
+1,501
| +2% | +$47.2K | 1.71% | 15 |
|
|
2015
Q3 | $2.86M | Sell |
95,866
-109
| -0.1% | -$3.5K | 1.55% | 15 |
|
|
2015
Q2 | $3.05M | Sell |
95,975
-1,808
| -2% | -$58.9K | 1.55% | 17 |
|
|
2015
Q1 | $3.23M | Buy |
97,783
+169
| +0.2% | +$5.37K | 1.64% | 15 |
|
|
2014
Q4 | $2.88M | Buy |
97,614
+1,431
| +1% | +$41K | 1.46% | 20 |
|
|
2014
Q3 | $2.7M | Sell |
96,183
-1,417
| -1% | -$39.8K | 1.43% | 20 |
|
|
2014
Q2 | $2.75M | Sell |
97,600
-10,275
| -10% | -$293K | 1.42% | 23 |
|
|
2014
Q1 | $3.29M | Sell |
107,875
-2,387
| -2% | -$71.2K | 1.79% | 11 |
|
|
2013
Q4 | $3.2M | Sell |
110,262
-4,091
| -4% | -$119K | 1.82% | 14 |
|
|
2013
Q3 | $3.12M | Sell |
114,353
-454
| -0.4% | -$12.4K | 2.06% | 13 |
|
|
2013
Q2 | $3.05M | Buy |
+114,807
| New | +$3.17M | 1.97% | 13 |
|
Other funds holding PFE
VCM
VPM
Ironwood Investment Counsel's PFE Position: Q1 2026 in Review
Ironwood Investment Counsel increased its Pfizer (PFE) stake by 6% in Q1 2026, buying an estimated $26.9K and bringing the position to 17,703 shares worth $497K. The position accounts for 0.07% of the portfolio, ranked #178.
Ironwood Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.56M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Ironwood Investment Counsel held 17,703 shares of Pfizer worth $497K as of Q1 2026.
- Ironwood Investment Counsel bought 1,009 Pfizer shares in Q1 2026, an estimated $26.9K.
- Pfizer made up 0.07% of Ironwood Investment Counsel's portfolio in Q1 2026, its #178 holding.
- Ironwood Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Ironwood Investment Counsel's Pfizer position peaked at $7.56M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Ironwood Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.